-
Cardiff City lose compensation case over Emiliano Sala death
-
Several French far-right mayors take down EU flags
-
Air Canada CEO to retire after row over English-only condolence message
-
Oil rises on Trump's Iran threats, stocks take cue on talks
-
Syrian leader pledges to work with Germany on migration, recovery
-
AI agent future is coming, OpenClaw creator tells AFP
-
Cardiff lose 122 mn euro compensation case over Emiliano Sala death
-
Tuchel defends Rice and Saka after England withdrawals
-
G7 ministers tackle economic fallout of Mideast war
-
Tottenham close in on De Zerbi as next boss - reports
-
Kenya's former NY marathon champion Korir gets 5-year doping ban
-
Lukaku says 'could never turn back on Napoli' after treatment row
-
Syrian leader visits Germany to talk war, recovery, refugees
-
Renault says developing ground-based military drone
-
Iran hangs two 'political prisoners' from banned opposition: activists
-
Russia expels UK diplomat on spying allegations
-
Premier League fans back call to scrap VAR
-
Italy hoping to scale World Cup 'Everest' ahead of Bosnia play-off showdown
-
Japan's cherry blossom season dazzles locals and tourists
-
EU ups mackerel quotas to match UK despite overfishing concerns
-
Crude rises, stocks drop as Houthi attacks escalate Iran war
-
Australian Rules player banned for wiping blood on face of opponent
-
Sheep culls put pressure on Greek feta cheese production
-
One man, his dog, and ChatGPT: Australia's AI vaccine saga
-
Israel PM restores access after Latin Patriarch blocked from Holy Sepulchre
-
Israel strikes Tehran as Trump says Iran deal may be reached 'soon'
-
Italy chase World Cup spot as Kosovo bid to make debut
-
Myanmar paves way for junta chief to become civilian president
-
'Long live the shah': Iranian diaspora back war at Washington rally
-
Taiwan opposition leader accepts Xi's invitation to visit China
-
French masonic lodge at heart of murky murder trial
-
US military building 'massive complex' beneath White House ballroom project: Trump
-
IPL captain takes pop at Cricket Australia over record-buy Green
-
G7 ministers set to tackle financial fallout of Mideast war
-
Premier League fans feel the pinch from ticket price hikes
-
Australia to halve fuel tax in response to Middle East war
-
Crude surges, stocks dive as Houthi attacks escalate Iran war
-
Air China resumes flights to North Korea after 6-year pause
-
NBA-best Thunder beat Knicks as Boston seal playoff spot
-
Australian fugitive shot dead by police after seven-month manhunt
-
King Kimi, Max misery, Bearman smash: Japan GP talking points
-
Philippines oil refinery secures 2.5 mn barrels of Russian crude
-
Trump says Russia can deliver oil to Cuba
-
All Blacks prop Williams out of Super Rugby season with back infection
-
Life with AI causing human brain 'fry'
-
Dubious AI detectors drive 'pay-to-humanize' scam
-
Test star Carey the hero as South Australia win Sheffield Shield final
-
Defending champ Kim Hyo-joo holds off Korda to win LPGA Ford Championship
-
Implacable Sinner overpowers Lehecka to win Miami Open
-
Australian police shoot dead fugitive wanted for killing officers
US abortion ruling threatens access to arthritis drug
When Alabama nurse Melissa went to pick up her regular prescription for rheumatoid arthritis last week, she was told the drug was "on hold" while the pharmacist checked she wasn't going to use it to induce an abortion.
"He said, 'Well I have to verify if you're on any contraceptives to prevent pregnancy.' The hell you do," she recalled thinking.
Melissa -- who is in her early forties and asked to be identified only by her first name for fear that speaking out might affect her livelihood -- then called her doctor, who succeeded in having the pharmacy in the southern US state release the medicine.
"I picked it up a couple hours later, but I felt violated," she told AFP, explaining she had had a hysterectomy six years ago, and that her lack of recent contraceptive history may have led the pharmacist to suspect she was pregnant.
Stories of people facing similar struggles have come to light in the weeks since the United States Supreme Court overturned Roe v Wade on June 24, highlighting an overlooked consequence of new state-level bans or severe restrictions on abortion.
It's not yet clear how widespread the cases are, but national organizations including the Lupus Foundation of America and the American College of Rheumatology said they were aware of such concerns and asking people affected to come forward.
"The Arthritis Foundation supports unencumbered access to and coverage of FDA-approved drugs for managing arthritis in alignment with scientific and clinical guidelines, as well as evidence-based medical recommendations," the organization said.
The issue centers on methotrexate, a drug which tempers inflammation and is commonly used against autoimmune conditions including inflammatory arthritis, psoriasis and lupus.
Methotrexate stops cell division and is given in higher doses as a cancer drug.
It can also sometimes be used in medical abortions, though not as frequently as the Food and Drug Administration-approved combination of two other drugs, mifepristone and misoprostol.
Nevertheless, many states have passed laws carrying threats of legal action against health care workers and pharmacies providing methotrexate.
- 'It's terrifying' -
Another woman contacted by AFP, a 20-year-old university student from Ohio, said she has had a methotrexate prescription since 2020 to treat her lupus, which affects her kidney and liver and causes joint pain.
A pharmacist at a national chain told her they were "no longer accepting prescriptions for methotrexate unless it was for the FDA-approved use of (treating) breast cancer, or the patient was not presumably fertile," she said.
She tried again, without success, to fill her prescription at a family-owned pharmacy, and this week got a letter from her doctor's office stating the practice would no longer be prescribing methotrexate because of the number of patients having difficulty accessing it.
Though the first pharmacy later changed its position, the experience left her "annoyed and angry," she said.
A third woman, 48-year-old Jennifer Crow, a writer and produce gardener in Tellico Plains, Tennessee, told AFP she received an automated call from CVS saying her methotrexate refill had been declined "pending provider approval."
Crow said Methotrexate had helped her enormously in managing her inflammatory arthritis, allowing her to roll out of bed and get dressed without severe pain, and walk without a cane for the first time in years.
Though her doctor was able to resolve the situation, Crow, who has also had a hysterectomy, said she was worried for other chronic illness patients who didn't have the same access to resources that she does.
In statements to AFP, national pharmacy chains CVS and Walmart confirmed they were working to adhere to new state regulations in light of the high court's decision to revoke the constitutional right to an abortion.
CVS added: "We encourage providers to include their diagnosis on the prescriptions they write to help ensure patients have quick and easy access to medications."
Alisa Vidulich, policy director of the Arthritis Foundation, told AFP she was hopeful the situation might be remedied quickly as medical professionals and pharmacies developed new guidelines.
"But that may not actually be the case in all states and it may in fact turn into a longer term issue," she acknowledged.
Melissa, the nurse, said she was incensed at the double standard that allowed one of her best friends, who is a man, to get his methotrexate prescription filled right away with no questions asked.
"We're headed in the wrong direction and it's terrifying. I have two daughters. I don't want to see this," she said.
E.Hall--AT